GK

Ganesan Kalaiyarasan

Active Director Director DIN 09420627
DIN 09420627 First appointment Dec 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value •••• Premium profile

About Ganesan Kalaiyarasan

Data last updated:

Ganesan Kalaiyarasan is a Director at Vivaana Pharma Private Limited (since 2021). The company operates in Trading. Vivaana Pharma Private Limited reported revenue of ₹27.6 Lakh (FY 2025).

DIN 09420627
Primary Designation Director
Industry Trading
First Appointment 01 Dec 2021
Oldest Company Age 4 yrs
Largest company Vivaana Pharma Private Limited · ₹27.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vivaana Pharma Private Limited U51909TN2021PTC148325
Director01 Dec 20212021₹27.6 Lakh (FY 2025)Active

Board colleagues of Ganesan Kalaiyarasan

Directorship timeline

Open interactive timeline →
Vivaana Pharma Private Limited
Premium access

Shareholding and investment profile for Ganesan Kalaiyarasan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ganesan Kalaiyarasan

Ganesan Kalaiyarasan currently holds 1 directorship: Vivaana Pharma Private Limited (Director, since 01 Dec 2021, revenue ₹27.6 Lakh (FY 2025)).

Ganesan Kalaiyarasan was first appointed on 01 Dec 2021 as Director at Vivaana Pharma Private Limited.

The current boards of Ganesan Kalaiyarasan's companies include Mohan Padhmanaban (Vivaana Pharma Private Limited), Rajaraman Ramya (Vivaana Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available